Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-28

Clinical Trial Update: Virtual Reality-based Eye Movement Desensitisation and Reprocessing Therapy for Specific Phobias [NA]

View source ↗

Summary

A completed clinical trial evaluating virtual reality-based Eye Movement Desensitisation and Reprocessing therapy for specific phobias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Northampton | Conditions: Specific Phobias | NA | Status: COMPLETED